Risk for Liver Cancer Down With Low-Dose Aspirin in Hepatitis B, C
WEDNESDAY, March 11, 2020 -- Low-dose aspirin is associated with a reduced risk for hepatocellular carcinoma among patients with chronic viral hepatitis, according to a study published in the March 12 issue of the New England Journal of...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Aspirin | Cancer | Cancer & Oncology | Carcinoma | Hepatitis | Hepatitis B | Hepatocellular Carcinoma | Liver | Liver Cancer | Pharmaceuticals | Study | Urology & Nephrology